Jeyanthi Ramanarayanan, MD
- Attending Physician Hematology/Oncology
Education
- Fellowship in Hematology/Oncology at Roswell Park Cancer Institute
- Internal Medicine Residency training at Mount Sinai School of Medicine at Jersey City Medical Center
- Medical School training at Sri Ramachandra Medical College and Research Institute, Chennai, India
Research Focus
Predictors of response to chemoradiation in advanced laryngeal cancer patients PTSD and cancer treatment outcome.
Selected Recent Publications
Ramanarayanan J, Hernandez-Ilizaliturri FJ, Chanan-Khan A, Czuczman MS. Pro-apoptotic therapy with the oligonucleotide Genasense™ (oblimersen sodium) targeting Bcl-2 protein expression enhances the biological anti-tumor activity of rituximab. Br J Haematol. 2004 Dec;127(5):519-30. PMID: 15566355.
Ramanarayanan J, Dunford LM, Baer MR, Sait SN, Maria Baer, Lawrence W, McCarthy PL. Chronic myeloid leukemia after treatment of lymphoid malignancies: Response to imatinib mesylate and favorable outcomes in three patients. Leuk Res. 2005 Dec 2; PMID: 16330096
Janet S. Winston, MD, Jeyanthi Ramanarayanan, MD, Ellis Levine, MD. HER2/neu evaluation in Breast Cancer: Are we there yet? Am J Clin Pathol. 2004 Jun;121 Suppl:S33-49 PMID 15298149
Adrienne Rencic, MD, PhD, Jeyanthi Ramanarayanan, MD. Leukemia Cutis. Dermatology, Internal Medicine Section in E-medicine Journal.
|
|
| Contacts |
|
|
Address
Hematology/Oncology Division
Department of Medicine
Stratton VA Medical Center
113, Holland Ave
Albany NY 12208
|
|
|
Phone
(518) 626-6380
|
| |
|
